Company Filing History:
Years Active: 2013
Title: Falk Nimmerjahn: Innovator in Polypeptide Research
Introduction
Falk Nimmerjahn is a prominent inventor based in Munich, Germany. He is known for his significant contributions to the field of biochemistry, particularly in the development of polypeptides with enhanced therapeutic properties. His work has the potential to impact the treatment of inflammatory diseases.
Latest Patents
Nimmerjahn holds a patent for "Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods." This invention provides a polypeptide containing at least one IgG Fc region, wherein said region is glycosylated with at least one galactose moiety connected to a respective terminal sialic acid moiety by an α 2, 6 linkage. The polypeptide exhibits higher anti-inflammatory activity compared to an unpurified antibody. He has 1 patent to his name.
Career Highlights
Falk Nimmerjahn is affiliated with The Rockefeller University, where he conducts his research. His work focuses on the development of innovative therapeutic agents that can improve patient outcomes in various inflammatory conditions.
Collaborations
Nimmerjahn has collaborated with notable researchers in his field, including Jeffrey V Ravetch and Yoshikatsu Kaneko. These collaborations have furthered the understanding and application of his research findings.
Conclusion
Falk Nimmerjahn is a key figure in the advancement of polypeptide research, with a focus on enhancing anti-inflammatory properties. His innovative work continues to pave the way for new therapeutic strategies in medicine.